WVU Cancer Institute participating in gynecologic cancer clinical trial

WVU Cancer Institute participating in gynecologic cancer clinical trial

MORGANTOWN, W.Va. – The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat cervical and vaginal cancer. 

Valerie Galvan Turner, M.D.
Valerie Galvan Turner, M.D.

Valerie Galvan Turner, M.D., gynecologic oncologist at the WVU Cancer Institute, will help lead the trial to evaluate whether Triapine (3AP), a medication that has been effective in the treatment of other cancers, leads to better outcomes in women with cervical and vaginal cancer when given in addition to traditional treatments.

“The WVU Cancer Institute’s participation in this clinical trial reaffirms our dedication to research in the field of cancer,” Dr. Galvan Turner said. “This will be a major contribution to the knowledge surrounding the treatment of gynecologic cancers.”

To be included in the trial, patients must have a pathologic diagnosis of Stage IB2-IVA cervical cancer (squamous, adenocarcinoma, adenosquamous) or Stage II-IVA vaginal cancer not amenable to curative surgical resection alone and ECOG performance status of 0-2. Patients must also be able to tolerate PET CT scans.

This trial offers the current standard of care plus the potential for an additional drug that may offer survival advantage for women with newly diagnosed cervical cancer. Patients who participate in the trial will receive additional monitoring to assess the effectiveness of the drug.

“We are excited to bring this clinical trial to West Virginia and the WVU Cancer Institute,” Dr. Galvan Turner said. “This treatment has the potential to allow for more options for patients for whom other treatments may not be effective.”

For more information: Heather Sammons, Communications Specialist, 304-285-7256
  • WVU Heart and Vascular Institute physicians use ECMO to address complicated airway

    WVU Heart and Vascular Institute physicians use ECMO to address complicated airway

    Physicians at the WVU Heart and Vascular Institute have used extracorporeal membrane oxygenation, or ECMO, to provide oxygen to a patient while she underwent rigid bronchoscopy to relieve complete airway obstruction. This is the first time ECMO has been used in the state to address a complicated airway.

    Read More

  • Esophageal diseases: New minimally invasive treatments

    Esophageal diseases: New minimally invasive treatments

    The WVU Heart and Vascular Institute’s Center for Esophageal Disease is here to provide you with the most cutting-edge therapies in the state of West Virginia for diseases of the esophagus. Our expert diagnosis and treatment methods are available to help you with a variety of esophageal conditions. We examine the issue closely with highly-advanced imaging and diagnostics, and our minimally invasive and robotic surgery options will have you back to your normal routine sooner than most procedures.

    Read More

  • WVU Medicine Urgent Care in McHenry receives accreditation from the Urgent Care Association

    WVU Medicine Urgent Care in McHenry receives accreditation from the Urgent Care Association

    The WVU Medicine Urgent Care in McHenry has received the Accredited Urgent Care designation, the highest level of distinction for urgent care centers, from the Urgent Care Association.  

    Read More